Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03552029 |
| Title | Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Daiichi Sankyo, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Ronald Reagan Medical Center, UCLA | Los Angeles | California | 90095 | United States | Details | |
| Yale Cancer Center | New Haven | Connecticut | 06510 | United States | Details | |
| University of Kansas Cancer Center | Fairway | Kansas | 66205 | United States | Details | |
| Rogel Cancer Center, University of Michigan | Ann Arbor | Michigan | 48109 | United States | Details | |
| Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14263 | United States | Details | |
| Duke University Cancer Center | Durham | North Carolina | 27710 | United States | Details | |
| Sidney Kimmel Cancer Center, Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |